Methylomic profiling in trisomy 21 identifies cognition and Alzheimer’s disease-related dysregulation
Posté le 9 March 2020.
Methylomic profiling in trisomy 21 identifies cognition- and Alzheimer’s disease-related dysregulation A study on DNA methylation at the genome level has just been carried out in partnership with the CRB BioJeL, the Institut Jérôme Lejeune and the Institute of Human Genetics of the University of Würzburg in Germany. This study confirms that Trisomy 21 patients […]
Lire la suite...